PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus

Table 2 Independent risk factors influencing PGLYRP2 level

Subject	β	SE	β’	t	P	β (95%CI)
Subject	β	SE	β’	t	P	Lower	Upper
Constant	4872.328	534.883		9.109	0.000	3768.383	5976.273
SLEDAI	57.199	18.537	0.716	3.086	0.005	18.940	95.459
C3	−1.224	44.267	−0.010	−0.028	0.978	−92.585	90.138
C4	−290.858	1318.002	− 0.073	− 0.221	0.827	− 3011.081	2429.365
GFR	−1.962	3.365	−0.113	−0.583	0.565	−8.908	4.983
24 h urine protein	0.026	0.034	0.124	0.775	0.446	−0.043	0.096
IgA	−45.934	69.554	−0.117	−0.660	0.515	− 189.487	97.618
HDLC	−69.796	194.271	−0.076	−0.359	0.723	− 470.750	331.159
APOA1	−109.037	396.500	−0.061	−0.275	0.786	− 927.372	709.298
apo-B/A1	−41.092	181.885	−0.054	−0.226	0.823	−416.484	334.300

β, beta coefficient; SE, standard error; β’, standardized beta coefficient; β (95%CI), 95% confidence interval of beta coefficient

ISSN: 1476-511X